GO:0015135 glucuronate transmembrane transporter activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0015135 describes the molecular function of moving glucuronate, a uronic acid derived from glucose, across a biological membrane.
• Glucuronate transport is central to drug metabolism and detoxification because many xenobiotics and endogenous compounds are conjugated with glucuronic acid before export.
• Several ATP-binding cassette (ABC) transporters and multidrug resistance-associated proteins (MRPs) recognize glucuronate conjugates as substrates.
• Bacterial ABC systems can import acidic polysaccharides such as alginate, which contains glucuronate-like residues, providing structural insight into glucuronate transport.
• Assays for glucuronate transmembrane transporter activity typically use radiolabeled or fluorescent glucuronide conjugates in vesicle or cell-based systems.
• CRISPR knockout, point-mutation, knock-in and overexpression models are powerful tools to dissect the causal role of candidate glucuronate transporters.
Description
Glucuronate transmembrane transporter activity (GO:0015135) is a molecular function that enables the transfer of glucuronate from one side of a membrane to the other. Glucuronate is the uronic acid formally derived from glucose by oxidation of the hydroxymethylene group at C-6 to a carboxyl group. This activity is essential for the disposition of glucuronide conjugates, which are formed by uridine diphosphate glucuronosyltransferases (UGTs) and then exported from cells by specific transporters. Understanding this function is critical for pharmacology, toxicology, and drug development because glucuronidation is a major phase II metabolic pathway. Researchers study glucuronate transmembrane transporter activity to explain how cells handle endogenous waste products and xenobiotics. Multidrug resistance-associated proteins (MRPs), such as MRP2 (ABCC2), are well-known export pumps for glucuronate conjugates, and mutations in these transporters can alter substrate specificity and cause disease. In bacteria, ABC transporters that import acidic polysaccharides like alginate provide structural and mechanistic parallels for glucuronate-containing substrate recognition. Thus, GO:0015135 bridges fundamental membrane biology with clinically relevant drug transport and detoxification. This article synthesizes authoritative QuickGO annotation and verified PubMed literature to describe the definition, mechanism, key genes, disease links, and experimental methods for studying glucuronate transmembrane transporter activity. It is intended for researchers who need a concise, citable overview for grant writing, experimental design, or generative-AI retrieval.
glucuronate transmembrane transporter activity At A Glance
| GO ID | GO:0015135 |
|---|---|
| GO term | glucuronate transmembrane transporter activity |
| Ontology | molecular_function |
| Synonym | (none) |
| Major function | Transfer of glucuronate across a membrane |
| Definition source | QuickGO |
| Related transporters | MRPs/ABCCs, bacterial ABC transporters |
| Substrate | Glucuronate and glucuronide conjugates |
| Directionality | Export or import depending on transporter |
What Is GO:0015135?
GO:0015135 (glucuronate transmembrane transporter activity) is defined as enabling the transfer of glucuronate from one side of a membrane to the other. Glucuronate is the uronic acid formally derived from glucose by oxidation of the hydroxymethylene group at C-6 to a carboxyl group. This activity is a molecular function that can be carried out by transporters that recognize glucuronate or glucuronate-containing conjugates as substrates.
Why Is glucuronate transmembrane transporter activity Important in Cell Biology?
Glucuronate transmembrane transporter activity is important because it controls the cellular efflux and influx of glucuronide conjugates, which are key end products of phase II drug metabolism. Without efficient transport, these conjugates can accumulate and cause toxicity, or they may fail to reach their target compartments. This function also affects drug bioavailability, resistance to chemotherapy, and the handling of endogenous compounds such as bilirubin and steroids. Consequently, understanding GO:0015135 helps researchers predict drug-drug interactions, design better therapeutics, and interpret genetic variants in transporter genes.
• Enables export of glucuronide conjugates, a major route for drug and xenobiotic elimination.
• Contributes to multidrug resistance by pumping out conjugated drugs from cancer cells.
• Supports hepatic and renal clearance of endogenous waste products.
• Influences pharmacokinetics and drug-drug interactions involving UGT substrates.
• Provides a mechanism for bacterial uptake of acidic polysaccharides like alginate.
• Mutations in transporter genes can alter substrate specificity and cause transport deficiencies.
• Is a potential target for modulating detoxification pathways in disease.
• Helps explain interindividual variability in drug response.
• Links membrane transport to metabolic disorders and cholestasis.
• Offers a functional readout for CRISPR-based screens of transporter genes.
What Happens During glucuronate transmembrane transporter activity?
Substrate recognition and binding
In simple terms: The transporter first grabs the glucuronate molecule.
Transport begins when a membrane protein recognizes glucuronate or a glucuronate conjugate. For MRP2 (ABCC2), mutation of Trp1254 alters substrate specificity and can abolish methotrexate transport, indicating that specific residues govern substrate selection. Similarly, bacterial ABC transporters that import alginate, an acidic polysaccharide containing glucuronate-like residues, use dedicated binding proteins to capture their substrates.
Conformational change and translocation
In simple terms: The transporter changes shape to move the molecule across the membrane.
After binding, the transporter undergoes conformational changes that shuttle glucuronate from one side of the membrane to the other. Structural studies of a bacterial ABC transporter involved in alginate import reveal the architecture of the translocation pathway and the role of nucleotide-binding domains in driving transport. For MRPs, ATP hydrolysis provides the energy for export of glucuronate conjugates.
Energy coupling and regulation
In simple terms: The cell uses energy to power the transport and can adjust it as needed.
Most glucuronate transporters are ATP-binding cassette (ABC) proteins that couple transport to ATP hydrolysis. The activity can be regulated by substrate availability, cellular energy status, and expression levels of the transporter. For example, MRP2-mediated transport of glucuronide conjugates is influenced by the presence of other drugs and natural compounds, as shown for steviol glucuronide.
Release and recycling
In simple terms: The molecule is released on the other side, and the transporter resets.
Following translocation, glucuronate is released into the extracellular space or target compartment. The transporter then returns to its resting state to begin another cycle. This cycle is essential for the continuous export of glucuronide conjugates and for maintaining cellular homeostasis. In bacteria, the imported alginate is further processed, demonstrating the physiological importance of the transport step.
Key Genes Involved in GO:0015135 glucuronate transmembrane transporter activity
The following genes encode proteins that exhibit or are directly associated with glucuronate transmembrane transporter activity, based on verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ABCC2 (MRP2) | Export pump for glucuronate conjugates | Mutations alter substrate specificity and cause transport deficiency |
| ABCC1 (MRP1) | Multidrug resistance-associated protein | Exports glutathione, glucuronate and sulfate conjugates |
| ABCC3 (MRP3) | Organic anion transporter | Contributes to glucuronide efflux in liver and intestine |
| ABCC4 (MRP4) | Nucleotide and conjugate transporter | Implicated in drug resistance and transport of glucuronides |
| UGT1A1 | Glucuronidation of bilirubin and drugs | Produces glucuronide conjugates that are substrates for transporters |
| UGT2B7 | Glucuronidation of opioids and steroids | Generates glucuronides exported by MRPs |
| SLCO1B1 | Organic anion transporting polypeptide | Influences hepatic uptake of glucuronides |
| SLC22A1 | Organic cation transporter | May transport glucuronide conjugates in kidney |
| ABCG2 (BCRP) | ABC transporter | Can transport glucuronide conjugates and affect drug resistance |
| ABCB1 (P-gp) | Multidrug efflux pump | Broad substrate specificity including some glucuronides |
| Alginate ABC transporter (bacterial) | Import of acidic polysaccharide alginate | Structural model for glucuronate-containing substrate transport |
| Bacterial ABC transporter system | Uptake of macromolecules | Provides mechanistic insight into ABC-mediated import |
| MRP2 Trp1254 mutant | Altered substrate specificity | Shows residue-level control of transport |
| Steviol glucuronide transporter | Transport of steviol glucuronide | Model for drug-natural compound interactions |
| Caffeic acid conjugates | Glucuronidation and transport | Linked to hepatocarcinoma pharmacology |
How Is glucuronate transmembrane transporter activity Regulated?
Glucuronate transmembrane transporter activity is regulated at multiple levels. Expression of MRP2 and other ABC transporters can be induced by nuclear receptors such as PXR and CAR in response to xenobiotics. Post-translational modifications and membrane trafficking also control the amount of transporter at the cell surface. Additionally, substrate availability from UGT-mediated glucuronidation influences transport rates, as seen with steviol glucuronide and its interaction with drugs and natural compounds. In bacteria, the expression of alginate import systems is regulated by environmental signals and nutrient availability.
glucuronate transmembrane transporter activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ABCC2 (MRP2) | Cholestasis, conjugated hyperbilirubinemia | Knockout mouse or HepG2 KO cells |
| ABCC1 (MRP1) | Multidrug resistance in cancer | Cancer cell lines with overexpression or KO |
| UGT1A1 | Gilbert syndrome, drug-induced hyperbilirubinemia | Patient-derived iPSC hepatocytes |
| ABCC3 (MRP3) | Drug resistance and liver injury | Knock-in reporter cell lines |
| Steviol glucuronide transporter | Drug-natural compound interactions | Transport assays in MDCK or HEK293 cells |
Drug resistance in cancer
Overexpression of MRPs and other ABC transporters that export glucuronate conjugates contributes to multidrug resistance in cancer cells. These pumps reduce intracellular drug concentrations, limiting the efficacy of chemotherapy. Understanding glucuronate transport can guide the development of inhibitors or substrate analogs to overcome resistance.
Hepatic and biliary disorders
MRP2 (ABCC2) dysfunction leads to impaired biliary excretion of glucuronide conjugates, causing conjugated hyperbilirubinemia and cholestasis. Mutations such as Trp1254 in MRP2 alter substrate specificity and can result in loss of methotrexate transport, highlighting the clinical importance of glucuronate transporter activity.
Drug-drug interactions and pharmacokinetics
Competition for glucuronate transporters can alter the clearance of drugs and endogenous compounds. For example, steviol glucuronide transport is affected by selected drugs and natural compounds, which may change systemic exposure and toxicity. Such interactions are critical for predicting clinical outcomes.
Metabolic and inflammatory conditions
Altered glucuronidation and transport of caffeic acid conjugates have been studied in hepatocarcinoma, suggesting a role in cancer biology and oxidative stress. Additionally, glucuronate transport influences the disposition of steroids and bile acids, linking it to metabolic and inflammatory pathways.
From glucuronate transmembrane transporter activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of ABCC2 affect glucuronate transport? | CRISPR knockout in HepG2 or HEK293 cells |
| Does a specific point mutation alter substrate specificity? | Point-mutation knock-in of ABCC2 Trp1254 |
| Can a tagged transporter be tracked in live cells? | Knock-in of fluorescent tag (e.g., GFP) |
| Does overexpression increase drug resistance? | Overexpression of MRP1 in cancer cell lines |
| Which genes regulate glucuronate transport? | CRISPR library screening in transport-competent cells |
| How does steviol glucuronide interact with drugs? | Transport inhibition assays in polarized cells |
How to Study the glucuronate transmembrane transporter activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Vesicular transport assay | ATP-dependent uptake of glucuronides | MRP2 function |
| Fluorescent substrate efflux | Cellular export activity | Multidrug resistance |
| CRISPR knockout screen | Genes required for transport | Identify novel transporters |
| Cryo-EM | 3D structure of transporter | Mechanistic insight |
| RNA-seq | Expression of UGTs and transporters | Disease profiling |
| Proteomics | Protein abundance and modifications | Regulation studies |
| Transport inhibition assay | Drug-drug interactions | Steviol glucuronide |
| Site-directed mutagenesis | Residue-level function | Substrate specificity |
Transport assays with radiolabeled or fluorescent substrates
Direct measurement of glucuronate transmembrane transporter activity often uses radiolabeled glucuronides or fluorescent conjugates in inside-out membrane vesicles or intact cells. These assays quantify uptake or efflux and can be adapted for high-throughput screening.
CRISPR-based genetic screens
Genome-wide CRISPR knockout or activation screens can identify genes that regulate glucuronate transport. Cells are challenged with a cytotoxic glucuronide conjugate, and resistant or sensitive clones are sequenced to pinpoint transporters and regulatory factors.
Structural biology and cryo-EM
Cryo-electron microscopy and X-ray crystallography of bacterial ABC transporters involved in alginate import have revealed the architecture of glucuronate-containing substrate translocation. These structures inform mechanistic models for human transporters.
Expression profiling and proteomics
RNA-seq and quantitative proteomics can measure expression levels of UGTs and transporters, linking glucuronate transport capacity to disease states or drug treatments. Such data help prioritize candidate genes for functional validation.
How CRISPR Can Be Used to Study GO:0015135 glucuronate transmembrane transporter activity
Knockout
CRISPR knockout of candidate glucuronate transporter genes, such as ABCC2 or ABCC1, can abolish transport activity and reveal their contribution to drug resistance or detoxification. Knockout cell lines are valuable for validating substrate specificity and for identifying compensatory pathways.
Point Mutation
Point mutations can mimic naturally occurring variants or probe key residues. For example, mutating Trp1254 in MRP2 alters substrate specificity and eliminates methotrexate transport, demonstrating the power of CRISPR point-mutation models to dissect molecular determinants.
Knock-in
Knock-in of tags or reporter genes allows real-time tracking of transporter localization and dynamics. Tagged knock-in models of ABC transporters can be used to study trafficking and membrane insertion in live cells.
Overexpression
CRISPR activation or cDNA overexpression of glucuronate transporters can increase efflux capacity and confer drug resistance. Overexpression models are useful for testing inhibitors and for studying transport kinetics in a controlled background.
How EDITGENE Supports glucuronate transmembrane transporter activity Research
Researchers studying glucuronate transmembrane transporter activity-related genes often need to determine whether a candidate gene is causally involved in transport, drug resistance, or disease. EDITGENE provides a comprehensive suite of CRISPR services to generate precisely engineered cell models that answer these questions.
Contact EDITGENE today to design your custom CRISPR model for glucuronate transmembrane transporter activity research.
Frequently Asked Questions About glucuronate transmembrane transporter activity
What is glucuronate transmembrane transporter activity?
It is a molecular function (GO:0015135) that enables the transfer of glucuronate, a uronic acid derived from glucose, across a biological membrane.
What genes are involved in glucuronate transmembrane transporter activity?
Key genes include ABCC2 (MRP2), ABCC1 (MRP1), ABCC3, ABCC4, and UGT enzymes that produce glucuronide conjugates.
How is glucuronate transported across membranes?
Transporters such as MRPs use ATP hydrolysis to pump glucuronate conjugates out of cells, while bacterial ABC systems can import glucuronate-containing polysaccharides.
Why is glucuronate transport important for drug metabolism?
It eliminates glucuronide conjugates of drugs and xenobiotics, affecting drug clearance, bioavailability, and resistance.
What diseases are linked to glucuronate transporter dysfunction?
Dysfunction can cause cholestasis, conjugated hyperbilirubinemia, and multidrug resistance in cancer.
How can I study glucuronate transmembrane transporter activity in the lab?
Common methods include vesicular transport assays, fluorescent efflux assays, CRISPR screens, and structural biology.
What is the role of MRP2 in glucuronate transport?
MRP2 (ABCC2) is an export pump for glucuronate conjugates, and mutations like Trp1254 alter substrate specificity.
Can CRISPR be used to study glucuronate transporters?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are powerful tools to dissect transporter function.
What are the substrates of glucuronate transporters?
Substrates include glucuronate itself and glucuronide conjugates of drugs, bilirubin, steroids, and xenobiotics.
Where can I find validated CRISPR models for glucuronate transporter research?
EDITGENE provides custom knockout, point-mutation, knock-in, and overexpression cell models for glucuronate transporter genes.
Conclusion
Glucuronate transmembrane transporter activity (GO:0015135) is a fundamental molecular function that governs the movement of glucuronate and its conjugates across membranes. It plays critical roles in drug metabolism, detoxification, and multidrug resistance, with direct implications for human health and disease. By leveraging CRISPR-based models and advanced screening technologies, researchers can dissect the precise contributions of individual transporters and identify new therapeutic opportunities. EDITGENE offers a full spectrum of services to support these investigations, from knockout and point-mutation cell lines to library screening and bioinformatics. Whether you are studying cancer drug resistance, hepatic disorders, or bacterial transport, our team can help you generate publication-ready data on glucuronate transmembrane transporter activity.
References
- 1. Meech R et al.. 1997. Structure and function of uridine diphosphate glucuronosyltransferases.. Clin Exp Pharmacol Physiol 24(12):907-15 PMID: 9406655
- 2. Espíndola KMM et al.. 2019. Chemical and Pharmacological Aspects of Caffeic Acid and Its Activity in Hepatocarcinoma.. Front Oncol 9:541 PMID: 31293975
- 3. Zhou SF et al.. 2008. Substrates and inhibitors of human multidrug resistance associated proteins and the implications in drug development.. Curr Med Chem 15(20):1981-2039 PMID: 18691054
- 4. Homolya L et al.. 2003. Multidrug resistance-associated proteins: Export pumps for conjugates with glutathione, glucuronate or sulfate.. Biofactors 17(1-4):103-14 PMID: 12897433
- 5. Maruyama Y et al.. 2015. Structure of a Bacterial ABC Transporter Involved in the Import of an Acidic Polysaccharide Alginate.. Structure 23(9):1643-1654 PMID: 26235029
- 6. Wang M et al.. 2015. Transmembrane transport of steviol glucuronide and its potential interaction with selected drugs and natural compounds.. Food Chem Toxicol 86:217-24 PMID: 26525112
- 7. Ito K et al.. 2001. Mutation of Trp1254 in the multispecific organic anion transporter, multidrug resistance protein 2 (MRP2) (ABCC2), alters substrate specificity and results in loss of methotrexate transport activity.. J Biol Chem 276(41):38108-14 PMID: 11500505
- 8. Momma K et al.. 2000. A novel bacterial ATP-binding cassette transporter system that allows uptake of macromolecules.. J Bacteriol 182(14):3998-4004 PMID: 10869078
